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novo single vessel disease. However, the use of PSS for multivessel~oronary 
disease has not been well defined. Between 1118/90 and 1/3/95, 53 Pts 
(45 men end 8 women) underwent placement of 112 PSS (73 coronary 
and 39 biliary Stents) in 107 vessels (two vessels in 52 Pts and 3 vessels 
in 1 pt). The mean age was 62.4- 11 years. The majodty ot Pta (66°/o) 
had both vessels trcmted uring the same procedure, while 24"/0 underwent 
Staged (within 1 week) slanting and 20% had the 2nd vessel slanted 7.6 
:1:9.3 months later. 32 Pte (60%) had HTN and 23 Pts (43%) had diabetes 
mallltus. 43 Pts (53%) presented with unstable angina, 11 Its (21%) had a 
recent myocardial infarction and 41 pta ('/9%) had prior CABG. The vessels 
stented wore the LAD (7%), LCX (6%), RCA (P/o), and venous bypass grafts 
(80%). 8tenfing was successful in 52 Pts (g~,=). The mean pra-proeedural 
% stenosis was 72.4- 37 and the mean pest-precedurel % stenoals was 
2 ~ 2. No pt died in-hospital or had emergency CABG. 6 Pts (11%) had 
non-Q wave MI and 1 p! (..'~/,) had a Q-wave MI. 17 Pts (32%) requirsdbloed 
transfusions and 8 Pte (15%) required femoral artery repair. There were no 
eubecute slant thrembosis. Follow-up angiagraphy was available in 25 Pts 
(47%) after a mean of 5.6 =1:2.5 months with an average % stunoals of 26 ~- 
30. Angiographic rastenosis (> 50% stenoals) of 1 or more stents was seen in 
6 PIe (24%). At a mean toflow-up of 15 ~- 11 months, 3 Pts (S .'P/o) died. 3 Pts 
(5.7°/o) suffered MI. Revascularization (100% PTCA) wan performed in 17 Pts 
(32%) after a mean of 12 4- 10 months (27°/= target vessel revaScutadzation 
and 11% target lesion revasculadzation). The 2 year survival was estimated 
at 91% and the 2 year revascutadzation-frea survival was 5P/o. 
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In conclusion, 1) Multivessel slanting can be accomplished with a high 
acute success rate and low procedural complications; 2) Despite multivessal 
CAD, no Pt required CABG dudng follow-up; 3) The restenosls rate was 
similar to that of single vessel slanting, and subsequent revescularization 
reflected progression of disease at non-slanted sites. 
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~ Clinical Application of  Transcatheter Endovaecular 
Graft Placement for  Aortic Aneurysm 
KanJt Inoua" Mitsum Sato, Shunicht Tamaki, Tomoyuki Iwase, 
Tatsuo Fujioka, Ado Yamazato, Shlgem Kube, Yukl Yoshlda, Htay Than 1, 
Masaru Tanaka 1. ~ Talre~a Hospital and Kyolo University Hospital, Kyoto, 
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A new graft with a delivery system was developed to treat aortic aneurysm 
without surgery. The graft was constructed from Dacron cylinder, and the 
surface of the graft was supported by multiple dngs of extra-flexible wire. 
After the graft was delivered to the predetermined target point through the 
sheath, the graft was allowed to expand by its own flexibility and then pressed 
to the vessel by balloon dilation. The delivept system was easy to use, flexible" 
and small Even if the graft was released in an Inapprepdate position, the 
graft can be moved easily to the optimal position by a carrying wire. After five 
years of experimental studies, transcathster endovascular graft placement 
ustng the graft was paTformed for 14 patients with aortic aneurysm. There 
were 13 men and one woman, aged from 21 to 85 years. The graft with the 
delivery system were successfully inserted percutaneously in6 patients and 
through open artedotomles in 8 patients under local anesthesia. There were 
aortic dissection in 4 patients, abdominal aortic aneuwsm in 4, common 
lilac aneurysm in one, pseudo aneurysm in one, artedovenous fistula in 
one, descending thoracic aneurysm in 2, aortic arch aneurysm in one. The 
graft including 2bifurcated graft was successfully and uneventfully implanted 
in 13 patients. The technical failure occurred in one case. There was no 
precedure-related mo~allty. After the procedure, thrombosis of the aneurysm 
surrounding the graft was complete in 9 patients. The remaining 4 patients 
had either small proximal communication or distal communication. However, 
In these patients, aneurysm was gradually thrombozed in the most parts and 
have shown no evidence of enlargement dudng a mean follow up perioc~ 
of 4.5 months. There were no evidence of severe narrowing, migration, and 
distraction of the graft. Normal flow through the graft have been demonstrated 
up to now. Our early experiences demonstrated the efficacy and the safety 
of transcathetar endovascular graft placement using this new graft. 
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Ten Year l~nds In Medical Management and Case 
Patallty in ACUte Myocardial Infarction 
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Gairdner Hospital and Department of Public H~11, University of Western 
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Previous studies have shown that patterns of management of acute my. 
ecardlal infarction (AMt) can change quite rapidly. We correlated trends in 
management with trends in mortality. The following graph demonsbatee the 
10 year trends in medical management of acute myocardial intacbon in a 
community wide study of 5121 patients aged 25-60 whose symptom onset 
was outside hospital and who were treated in a corenary unit. 
,~ 7o -). ~ t  I 
0 - ; i B I 
IB~4 lg99 lg~B 1987 19~B 1989 1900 1991 1992 lg9~ 
Y~t 
There were dramatic uptrends in the use of aspidn and thmmbelytto herapy 
and a steady dee in the usa of beta-blockers, declining use of calcium channel 
blockers and anti-arrhythmIc drugs and a re~;ant increase th the use of ACE 
inblblters. 
In 1984/85 the 28 day case fatality was 8.6% declining to 4.6% in 1992/93 
(p < 0,001). This represents an improvement of 40 lives saved in the month 
past-infarction par 1000 patients treated in coronary cam units dudng the 
decade. This Is in excess of any effect which could be attributed to a single 
intepmntion, and is consistent with a benefit from the Combined changes In 
medical management. 
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~7-~'~ Reperfusion Therapy After Pre-Hoapltsl  Cardiac 
Arrest and Its Influence on Outcome After Acute 
Myocardial  Infarction 
B. Fendlay Stewart, W. Douglas Weaver, Lori S. Parsons, Jenny S. Martin, 
Nathan R. Every. University of Washington, Seattle, WA 
In the MITI registry of patients (pts) with acute myocardial infarction (AMI), 
599 (4.6%) of 12,984 pts had a cardiac arrest pdor to hospital ardvel. Twenty- 
six (4.4%) were In coma on admission. Thrembofyttc therapy was given to 53 
(8.8%) pts, none with coma. Direct PTCA was used In 59 (9.8%), including 3 
pts with coma. 
Age (mean) 
Prior history (%) 
MI 
Angina 
CHF 
Moffelity (%) 
Pro-hospital arrest end AMI AMI w/no arrest 
I g PTCA Ihrombolysis No Rx 
n=59 n-53 n=487 n.log~q=; 
59.5 58.5 67.2 66.1 
10.2 19.9 24.7 20.9 
20.3 20.8 24.7 33.1 
5.1 1.9 19.1 11.3 
24.1 12.5 58.2 9.9 
The mortality in the 23 pts with Coma who did not receive PTC/Z.,lhrembolytfc 
!herapy was 74%; 2 of 310ts wilh coma treated by PTCA also died, 
The mortality for patients with AMI who have be~n resuscitated from 
cardiac arrest is hi'0h. These findings suggest that aggressive reperfuslon 
strategies hould be pursued and their effectiveness tudied, pa~culady in 
pts who are neurologlcagy intact at the time of hospital admission. 
